Revance Therapeutics | 营业利润



Operating Profit 更改 日
AbbVie USD 3.73B 5.22B 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
J&J USD 13.63B 9.74B 2025-03
Merck USD 5.87B 1.57B 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
P&G USD 4.55B 1.21B 2025-03
Pacira USD 1.99M 22.71M 2025-03
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12



Revance Therapeutics 营业利润 - 当前值，历史数据，预测，统计，图表和经济日历 - Jul 2025.